European Life Sciences Perspective: Corporate, Competition, IP, and Collaboration Trends in the European Life Sciences Market — Session 2

The life sciences industry is undergoing transformation across the globe and facing challenges and opportunities arising from the coronavirus (COVID-19) pandemic. In addition, the United Kingdom’s exit from the European Union is expected to bring significant changes for the industry in relation to issues including pharmaceutical and medical device regulation, antitrust and competition, and corporate transactions.

Please join us for the second part of our webinar series. This session will examine corporate, antitrust and competition, intellectual property and collaboration trends impacting the European life sciences market.

Session 2: Corporate, Competition, IP, and Collaboration Trends in the European Life Sciences Market
Wednesday, October 7, 2020
10:00 am–11:00 pm ET | 3:00–4:00 pm BST

Tim Corbett, Partner, Corporate
Joachim Heine, Partner, Corporate
Omar Shah, Partner, Antitrust & Competition
Louis Beardell, Partner, Intellectual Property
Mike Pierides, Partner, Corporate
Jayne McGlynn, Associate, Corporate

Questions? Please contact stephanie.steedman@morganlewis.com

Don't miss Session 1: Current Trends and Brexit Implications on October 1.